Revance Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Revance Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Revance Therapeutics Inc Strategy Report
- Understand Revance Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Revance Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
12 Sep 2022 | Revance Therapeutics Raises USD230 Million in Public Offering of Shares | Equity Offering | - |
Revance Therapeutics Inc |
10 May 2022 | Revance Therapeutics to Raise USD150 Million in Public Offering of Shares | Equity Offering | - |
Revance Therapeutics Inc |
21 Mar 2022 | Revance Therapeutics Raises USD100 Million in First Tranche of Private Placement of 8.5% Notes Due 2026 | Private Equity |
Athyrium Capital Management LP
|
Revance Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer